The primary treatment approach for congenital hydrocephalus in children is the implementation of a Cerebrospinal Fluid (CSF) shunt. Even in the absence of pleocytosis or changes in CSF chemistries, a positive culture often indicates infection in patients with a compromised device. Healthcare professionals rely on this test to detect shunt malfunctions, facilitating the accurate selection of medical interventions.